Luly Jay R.
SEC insider (Form 3/4/5 filer). CIK 0001571211. President and CEO at ENANTA PHARMACEUTICALS INC (ENTA). 12 reported Form 4/5 transactions since Sep 2024; latest on Feb 12, 2026. Located in WATERTOWN, MA.
Companies Luly Jay R. has filed insider reports for
- ENANTA PHARMACEUTICALS INC (ENTA): Director, Officer, President and CEO
Luly Jay R.
CIK: 0001571211
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENANTA PHARMACEUTICALS INC
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect15.2K shares- - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect6.2K shares at avg. $14.25$88K - Feb 12, 2026ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect4.8K shares- - Dec 5, 2025ENTA
ENANTA PHARMACEUTICALS INC
SaleDirect4.7K shares at avg. $14.23$67K - Dec 1, 2025ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect1.9K shares at avg. $14.12$27K - Nov 25, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirectStock Option (right to buy)
310K shares- - Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
AwardDirect25.5K shares- - Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
Tax PaymentDirect7.5K shares at avg. $5.59$42K - Feb 12, 2025ENTA
ENANTA PHARMACEUTICALS INC
PurchaseDirect45K shares at avg. $5.69$256K - Dec 6, 2024ENTA
ENANTA PHARMACEUTICALS INC
SaleDirect5.1K shares at avg. $8.06$41K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Award | 15,200 | - | $0 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 6,155 | $14.25 | $87,709 | Direct |
| Feb 12, 2026 | ENTA ENANTA PHARMACEUTICALS INC | Award | 4,800 | - | $0 | Direct |
| Dec 5, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Sale | 4,743 | $14.23 | $67,493 | Direct |
| Dec 1, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 1,885 | $14.12 | $26,616 | Direct |
| Nov 25, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award Stock Option (right to buy) | 310,000 | - | - | Direct |
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Award | 25,500 | - | - | Direct |
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Tax Payment | 7,484 | $5.59 | $41,836 | Direct |
| Feb 12, 2025 | ENTA ENANTA PHARMACEUTICALS INC | Purchase | 45,000 | $5.69 | $256,050 | Direct |
| Dec 6, 2024 | ENTA ENANTA PHARMACEUTICALS INC | Sale | 5,142 | $8.06 | $41,445 | Direct |
1-10 of 12 transactions